HB 700 Summary

• Expands eligibility for injectable long-acting or extended-release forms of naltrexone and buprenorphine administration to include pharmacists, psychologists, chemical dependency professionals, counselors, social workers, emergency medical personnel, and police officers, in addition to physicians and physician assistants.

• Requires prescribers who prescribe opioid analgesics to offer administration of injectable naltrexone during business hours, with administration delegable to trained healthcare professionals under established protocols.

• Authorizes the state board of pharmacy to establish and maintain a drug database to monitor naltrexone administration and requires individuals administering these drugs to submit related information to the board.

• Mandates hospitals to maintain at least eight inpatient addiction treatment beds and an outpatient program or lose tax-exempt status and become subject to property and sales taxes.

• Directs the department of mental health and addiction services to procure injectable naltrexone and buprenorphine directly from manufacturers and distribute them through state and local agencies to individuals in need of addiction treatment.